Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Accurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...

Observed annually on March 10, National Women and Girls HIV/AIDS Awareness Day (NWGHAAD) 2025 serves as a crucial reminder of ...

Without public health surveillance, officials trying to tackle outbreaks, identify threats and evaluate treatments are working ‘in the darkness of ignorance.’ ...

Enormous progress has been made in tackling the global HIV epidemics over the past two decades. The number of people dying ...

A generation has passed since the world saw the peak in AIDS-related deaths. Those deaths—agonizing, from diseases or infections the body might otherwise fight off—sent loved ones into the streets, ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...